Click the following link to watch video:
https://insider.thomsonreuters.com/link.html?cn=share&cid=176535&shareToken=Mzo4YWQ2NDZlMS04NGQ4LTQxMDktOTViNS05ZWY5ZjdkZTM1YzQ%3D&playerName=ReutersNews
Source: Thomson Reuters
Description: Reuters Healthcare Correspondent Lewis Krauskopf
says expect more pressure on the insurance
industry because of the latest CVS deal.
(To access all exclusive Reuters Insider programming visit: http://insider.thomsonreuters.com)
Short Link: http://reut.rs/1BgziUM
Transcript (May be auto-generated)
Let's go Inside the News at 10AM. US stocks are down as investors appear poised
to grab profits after a recent rally. Still the S&P 500 is on track for its best
December performance since 1991. The index has gained 6.6% so far this month.
Meantime, treasury prices are up sending yields lower. This, as traders bought
longer-dated debt in an effort to square up their books. Bond market closing at
2PM Eastern today. Universal American shares are surging 36% after it said it's
selling its Medicare prescription drug business to CVS Caremark for about $1.25
billion. Reuters Healthcare Correspondent Lewis Krauskopf says the deal is going
to put pressure on others in the insurance industry. Lewis, why is CVS wanting
to do this deal and why now? Well it's really making them a much more formidable
competitor in the Medicare business, the Medicare Part D business in which they
offer prescription drug coverage under Medicare, which is the government program
for the elderly. And this is, it's going to more than double their membership to
over 3 million. And that will really make them a more formidable competitor
against the likes of Humana and UnitedHealth, which are sort of the titans in
this space and which have been bulking up themselves. Humana did a deal earlier
this year with WalMart to make a, to provide a more substantial offering in the
Medicare Part D space. It's also coming at a time when the post-war baby boom
mediation is aging in to Medicare. So there's going to be more growth in
Medicare over time, so that will position CVS a lot better. This is also a
population that goes to the drugstores and so there's the possibility, analysts
are saying that this will really help CVS capture more foot traffic in their
retail stores. Lewis, thanks for that. Shares of IMAX jumping about 12% this
hour.
This comes on a report that Sony is considering a $40-a-share bid for the big
screen movie company. That would be a total price tag of about $2.5 billion. The
UK's Daily Mail says Walt Disney may be interested as well. Euro's edging up to
a two-week high against the Dollar. The common currency is holding just above
its 100-day moving average on year-end buying by central banks. Analysts are not
favoring the Euro going forward. It's lost nearly 7% against the Dollar and over
18% against the Yen this year. Meantime, Estonia becomes the latest member of
the Euro Club when it joins on January 1.
In about half an hour, we get the latest read on the Economic Cycle Research
Institute's Leading Economic Index. The measure of future US growth expanded at
an annualized rate of 0.8% last week, that was at a 30-week high after hitting a
trough in August. Reuters Specialist Editor Dan Burns says based on historical
data, 2011 growth might surprise to the upside. Coming up at 1030, find out why
more prosperity does not necessarily lead to democracy, that's what MIT
Professor of Economics Daron Acemoglu is saying. And at 1100 EST, Reuters
Equities Analyst John Kozey tells us his best and worst share picks for the
year. I'm Rhonda Schaffler, this is Reuters Insider